Suraksha Diagnostic Limited (NSE:SURAKSHA)

India · Delayed Price · Currency is INR

259.00

-0.90 (-0.35%)

Jul 17, 2026, 3:30 PM IST

-20.17% (1Y)

Market Cap	13.54B -25.7%
Revenue (ttm)	3.10B +23.1%
Net Income	321.87M +1.1%
EPS	6.18 +3.5%
Shares Out	52.08M
PE Ratio	42.06
Forward PE	33.75
Dividend	0.50 (0.19%)
Ex-Dividend Date	n/a

Volume	13,294
Open	261.40
Previous Close	259.90
Day's Range	258.00 - 261.40
52-Week Range	224.10 - 333.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1992

Employees 1,300

Stock Exchange National Stock Exchange of India

Ticker Symbol SURAKSHA

Full Company Profile

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Financial Statements